首页 | 本学科首页   官方微博 | 高级检索  
检索        

氯吡格雷联合低分子肝素治疗缺血性脑卒中的疗效观察
引用本文:孙波,赵颖.氯吡格雷联合低分子肝素治疗缺血性脑卒中的疗效观察[J].中国现代医生,2014(11):43-44,47.
作者姓名:孙波  赵颖
作者单位:[1]山东省淄博市淄川区医院神经内科,山东淄博255100 [2]山东能源淄博矿业集团有限责任公司中心医院特检科,山东淄博255120
摘    要:目的 观察氯吡格雷联合低分子肝素治疗缺血性脑卒中的疗效.方法 对照组予低分子肝素钠5 000IU腹部皮下注射,每12小时1次,连用14 d.观察组同时加用氯吡格雷75 mg口服,每日1次,连用14d.结果 治疗后14 d,观察组和对照组的NIHSS评分均较治疗前及治疗后7d分别明显降低,且观察组的NIHSS评分较对照组降低更显著(P<0.05).两组均无一例死亡,观察组和对照组治疗后的总有效率分别为93.3%、83.3%,两组疗效比较差异有统计学意义(P<0.05).结论 氯吡格雷联合低分子肝素治疗缺血性脑卒中疗效确切、治愈率高、安全性好,值得临床推广和应用.

关 键 词:氯吡格雷  联合  低分子肝素  缺血性脑卒中

Efficacy of clopidogrel and LMWH in treatment of ischemic stroke
Authors:SUN Bo  ZHAO Ying
Institution:1.Department of Nerve Internal Medicine,the Hospital in Zichuan District of Zibo City in Shandong Province,Zibo 255100, China; 2.Special Prosecution Section,the Central Hospital of Shandong Zibo Mining Group Co.,Ltd.,Zibo 255120, China)
Abstract:Objective To observe the efficacy of clopidogrel and LMWH in treatment of ischemic stroke. Methods The control group were given abdominal subcutaneous low molecular weight heparin (LMWH)5 000 IU, every 12 hours once, for 14 d. Observation group plus clopidogrel 75 mg orally once a day, for 14 d. Results After treatment 14 days, the NIHSS scores of observation group and the control group were significantly reduced than before treatment and after treatment 7 days, and the observation group lowered more significantly than control group (P〈0.05). There were no deaths, the total efficiency of two groups were 93.3%, 83.3% (P〈0.05). Conclusion The low molecular weight heparin clopidogrel is effective in treating ischemic stroke, high cure rate, safety, worthy of promotion and application.
Keywords:Clopidogrel  Joint  Low molecular weight heparin  Ischemic stroke
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号